BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 27410037)

  • 1. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.
    Pan QZ; Liu Q; Zhou YQ; Zhao JJ; Wang QJ; Li YQ; Tang Y; Gu JM; He J; Chen SP; Weng DS; Xia JC
    Cancer Immunol Immunother; 2020 May; 69(5):825-834. PubMed ID: 32060687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients.
    Yang L; Ren B; Li H; Yu J; Cao S; Hao X; Ren X
    Cancer Immunol Immunother; 2013 Jan; 62(1):65-73. PubMed ID: 22744010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell-cytokine killer combined with microwave ablation reduced recurrence for hepatocellular carcinoma compared to ablation alone.
    Wang L; Li X; Dong XJ; Yu XL; Zhang J; Cheng ZG; Han ZY; Liu FY; Yu J; Liang P
    Technol Health Care; 2024; 32(3):1819-1834. PubMed ID: 38393935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up.
    Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
    Cancer Immunol Immunother; 2019 Jan; 68(1):23-32. PubMed ID: 30232520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Sun YP; Wang YZ; Liu SY; Yu HS; Li CW; Zeng XT; Chen L; Yao XS; Feng JH
    J Immunol Res; 2018; 2018():9081938. PubMed ID: 30648123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activation of cytotoxic T lymphocytes by fusion of mouse hepatocellular carcinoma cells and lymphotactin gene-modified dendritic cells.
    Sheng XL; Zhang H
    World J Gastroenterol; 2007 Nov; 13(44):5944-50. PubMed ID: 17990361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells.
    Qin W; Xiong Y; Chen J; Huang Y; Liu T
    J Cell Mol Med; 2018 Jul; 22(7):3364-3376. PubMed ID: 29566310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective effect of cytokine-induced killer cells on survival of patients with early-stage melanoma.
    Li H; Huang L; Liu L; Wang X; Zhang Z; Yue D; He W; Fu K; Guo X; Huang J; Zhao X; Zhu Y; Wang L; Dong W; Yan Y; Xu L; Gao M; Yang S; Zhang Y
    Cancer Immunol Immunother; 2017 Mar; 66(3):299-308. PubMed ID: 27889798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth of human colorectal cancer SW1116 cells is inhibited by cytokine-induced killer cells.
    Wang Y; Dai H; Li H; Lv H; Wang T; Fu X; Han W
    Clin Dev Immunol; 2011; 2011():621414. PubMed ID: 21455282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial.
    Matsui HM; Hazama S; Nakajima M; Xu M; Matsukuma S; Tokumitsu Y; Shindo Y; Tomochika S; Yoshida S; Iida M; Suzuki N; Takeda S; Yoshino S; Ueno T; Oka M; Nagano H
    Cancer Immunol Immunother; 2021 Apr; 70(4):945-957. PubMed ID: 33074442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer.
    Wang D; Zhang B; Gao H; Ding G; Wu Q; Zhang J; Liao L; Chen H
    BMC Cancer; 2014 Apr; 14():251. PubMed ID: 24720900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity.
    Nishimura R; Baker J; Beilhack A; Zeiser R; Olson JA; Sega EI; Karimi M; Negrin RS
    Blood; 2008 Sep; 112(6):2563-74. PubMed ID: 18565854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Therapeutic Potential of Cytokine-Induced Killer in Patients with Cancer.
    Zhong S; Zhang Y; Lu X; Meftahpour V
    J Interferon Cytokine Res; 2024 Mar; 44(3):99-110. PubMed ID: 38488758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma.
    Schmidt J; Eisold S; Büchler MW; Märten A
    Cancer Immunol Immunother; 2004 Nov; 53(11):1018-26. PubMed ID: 15185013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors.
    Jäkel CE; Vogt A; Gonzalez-Carmona MA; Schmidt-Wolf IG
    J Immunol Res; 2014; 2014():897214. PubMed ID: 24741629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of autologous dendritic cell cytokine-induced killer on refractory metastatic colorectal cancer: a matched case-control comparative study.
    Chang SC; Ke TW; Chen WT; Shyu WC; Jeng LB
    Front Immunol; 2024; 15():1329615. PubMed ID: 38476223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis.
    Li CMY; Tomita Y; Dhakal B; Li R; Li J; Drew P; Price T; Smith E; Maddern GJ; Fenix KA
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-induced killer cells hunt individual cancer cells in droves in a mouse model.
    Kim JS; Kim YG; Lee HK; Park EJ; Kim B; Kang JS; Lee H; Kim Y; Hong JT; Han SB
    Cancer Immunol Immunother; 2017 Feb; 66(2):193-202. PubMed ID: 27888293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cells.
    Li J; Lin W; Huang T; Chen M; Lin Q
    Exp Cell Res; 2024 May; ():114073. PubMed ID: 38704079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.